Mark Alan Smith - 30 Jun 2021 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Issuer symbol
VTGN
Transactions as of
30 Jun 2021
Net transactions value
+$4,399
Form type
4
Filing time
02 Jul 2021, 16:11:08 UTC
Next filing
03 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $4,399 +2,260 +23% $1.95 12,260 30 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on June 30, 2021 in a transaction exempt under Rule 16b-3(c).